Theromics Inc. is a cutting-edge company based in West Bridgewater, MA, specializing in the development of next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. Their proprietary HeatSYNC gel, derived from a naturally occurring protein in the body, aims to enhance the effectiveness of thermal ablation, leading to improved outcomes and cost-efficiencies. With a focus on tumor ablations initially, Theromics plans to expand into other applications such as pain management and abnormal uterine bleeding, while also exploring the potential of their thermal technology for oncolytic intratumoral drug immunotherapy delivery.
Utilizing their innovative HeatSYNC Gel, Theromics Inc. has successfully developed a novel thermal accelerant that augments MW and RF energy by increasing local tissue electrical conductivity in a reproducible and effective manner. This gel, applied next to or into the targeted lesion via a percutaneous needle stick, remains in place without migration and integrates into the treated area before being naturally absorbed by the body. While the device is currently for Investigational Use Only and has not yet received clearance from regulatory bodies, Theromics Inc. is dedicated to advancing their thermal technology to enhance the efficacy and safety profiles of approved medicines, ultimately revolutionizing soft tissue ablation procedures.
Generated from the website